Risk of GI Bleeding with Concurrent Use of Naproxen and Escitalopram

Mechanism of Increased Risk

NSAIDs like naproxen cause GI bleeding through direct mucosal damage and antiplatelet effects by inhibiting protective prostaglandins, according to Alimentary Pharmacology and Therapeutics and Clinical Gastroenterology and Hepatology 1, 2

NSAID use alone increases the risk of GI bleeding 2-4 fold compared to non-users, as reported by Clinical Gastroenterology and Hepatology and Praxis Medical Insights 2, 3

Advanced age increases risk approximately 4% per year, according to Praxis Medical Insights 3
History of previous peptic ulcer or GI bleeding increases risk 2.5-4 fold, as noted by Alimentary Pharmacology and Therapeutics and Praxis Medical Insights 1, 3
Concomitant use of corticosteroids increases risk approximately 2-fold, according to Alimentary Pharmacology and Therapeutics and Praxis Medical Insights 1, 3
Concomitant use of anticoagulants increases risk approximately 3-fold, as reported by Alimentary Pharmacology and Therapeutics and Praxis Medical Insights 1, 3
Higher doses of either medication increase risk in a linear dose-response relationship, according to Clinical Gastroenterology and Hepatology and Praxis Medical Insights 2, 3
Helicobacter pylori infection increases risk, as noted by Praxis Medical Insights 3

Use the lowest effective dose of naproxen for the shortest duration possible, as recommended by Praxis Medical Insights 3
Consider alternative pain management strategies that don't involve NSAIDs, according to Praxis Medical Insights 3
If the combination cannot be avoided, add gastroprotection with a proton pump inhibitor (PPI), as suggested by Circulation 4, 5
PPIs reduce the risk of upper GI bleeding by approximately 75-85% in high-risk NSAID users, according to Alimentary Pharmacology and Therapeutics 1
PPIs provide greater protection against GI bleeding than H2-receptor antagonists, as reported by Circulation 4, 5
Consider testing for and treating H. pylori infection if present, as recommended by Praxis Medical Insights 3

Enteric-coated or buffered preparations of NSAIDs do not clearly reduce the adverse gastrointestinal effects, according to Clinical Gastroenterology and Hepatology 2